Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C31 - Sticker Shock—Drug Pricing and Your Patients

Sunday 04/14/24
07:00 AM - 09:00 AM MDT Add To Calendar
Colorado Convention Center | 605
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Kavita Nair, PhD, FAAN
Practice, Policy, and Ethics
The high cost of newer, innovative medications to treat neurologic disease has created both excitement and challenges for all stakeholders in the US health care systems. Payers solely determine which drugs to pay for, which patient populations will be covered, what level to offer coverage and what cost sharing patients face. All aspects of this decision making leave out of the patient's voice. However, for patient preferences to be given adequate consideration by decision makers they need to be quantified. Through presentations from experts in patient preferences research, neurologists who have overcome access barriers by payers and those working with rare disease populations where patient preferences could differ from payer choices, faculty will facilitate an understanding of value assessment from the patient perspective for high cost drugs.
2.00 CME credits
Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:25 AM MDT Speaker The PAVE (Patient-driven Values in Healthcare Evaluation) Center Model for Assessing Patient Preferences
Julia Slejko, PhD
07:25 AM - 07:50 AM MDT Speaker The Cost to Latino Patients: High Cost Specialty Drugs in NMOSD
Rebecca Romero, MD, FAAN
07:50 AM - 08:15 AM MDT Speaker Busting Barriers for Patients: The Neurologists Magic Tricks
Rosemarie E. Walch, DO
08:15 AM - 08:40 AM MDT Speaker The Value Proposition of High Cost Drugs
Kavita Nair, PhD, FAAN
08:15 AM - 09:15 AM MDT Discussion Panel Discussion
Kavita Nair, PhD, FAAN, Rebecca Romero, MD, FAAN, Rosemarie E. Walch, DO, Julia Slejko, PhD
Faculty Disclosures
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS.
Rebecca Romero, MD, FAAN Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Rosemarie E. Walch, DO Dr. Walch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Walch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Walch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Walch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Walch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Walch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walch has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Walch has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Walch has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Walch has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Walch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Walch has received research support from Genentech/Roche. The institution of Dr. Walch has received research support from Sanofi. The institution of Dr. Walch has received research support from EMD Serono. Dr. Walch has received research support from TG Therapeutics . The institution of Dr. Walch has received research support from Novartis. The institution of Dr. Walch has received research support from Alexion. The institution of Dr. Walch has received research support from Amgen .
Julia Slejko, PhD Julia Slejko, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim . Julia Slejko, PhD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ISPOR. The institution of Julia Slejko, PhD has received research support from Genentech. The institution of Julia Slejko, PhD has received research support from PhRMA Foundation. The institution of Julia Slejko, PhD has received research support from National Health Council.